Status:

RECRUITING

A Intervention for Reducing Sedentary Behaviour Among Prostate Cancer Survivors

Lead Sponsor:

University of Toronto

Collaborating Sponsors:

Canadian Institutes of Health Research (CIHR)

Conditions:

Sedentary Behavior

Cancer of Prostate

Eligibility:

MALE

18+ years

Phase:

NA

Brief Summary

This randomized controlled trial (RCT) will aim to examine the effect of a 12-week behavioural intervention on changing the sedentary behaviours (SB) of prostate cancer survivors (PCS) compared to a c...

Detailed Description

Many prostate cancer survivors (PCS) suffer from long-term side effects well beyond treatment, such as urinary incontinence, erectile dysfunction, fatigue, depression, and anxiety. Supportive care int...

Eligibility Criteria

Inclusion

  • \>= 18 years of age
  • Diagnosed with localized or asymptomatic metastatic primary prostate cancer
  • Not currently undergoing radiation or chemotherapy
  • Proficient in English
  • Not physically active (self report \<150 minutes of moderate-to-vigorous physical activity per week)
  • Self-report \>8 hours of daily sedentary behaviour
  • In the contemplation or preparation stage for motivational readiness to change as determined by the Stages of Change Questionnaire
  • Access to a smartphone, tablet, or computer
  • No cardiac contraindications (e.g., unstable angina, arrhythmia, heart failure, aortic stenosis)
  • Medical clearance from a primary health care provider (if necessary)
  • Currently residing in Canada

Exclusion

  • Not planning to live in Canada for the next 12 months
  • A medical condition that prohibits walking (e.g., severe knee or hip arthritis)
  • Presence of other primary or recurrent invasive cancer (i.e., other than non-melanoma skin cancer)
  • Have had a prior fall within the last 12-months
  • Use a gait aid device

Key Trial Info

Start Date :

February 15 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT05214937

Start Date

February 15 2022

End Date

December 1 2026

Last Update

December 4 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Toronto

Toronto, Ontario, Canada, M5S 2W6